retatrutide glp-1 retatrutide Retatrutide, vs. Tirzepatide, vs. Semaglutide, Retatrutide vs. Cagrilintide Weight loss drug retatrutide use

The retatrutide dosage chart tells you the milligram target

Retatrutide is an investigational peptide that acts as a triple agonist at GIP, GLP-1, and glucagon receptors, currently in clinical development for obesity and type 2 diabetes (Jastreboff et al

Weight loss velocity peaks at approximately 0.8kg per week during this period

Pharmacol Ther 2007;113:54693 140

While regulatory bodies and pharmaceutical companies are discussing potential solutions to the drug shortages, societies such as the American Diabetes Association are providing guidelines to assist with alternative treatment options for patients with type 2 diabetes mellitus as well as guidelines to assist with dosage changes to be made while GLP-1 therapies are low in stock

Compounded semaglutide has also become a significant topic as access and cost concerns drive interest in alternatives to brand-name products